Concepts (112)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain Ischemia | 4 | 2022 | 250 | 2.310 |
Why?
|
| Stroke | 6 | 2022 | 998 | 2.190 |
Why?
|
| Tissue Plasminogen Activator | 2 | 2018 | 113 | 1.080 |
Why?
|
| Cerebral Hemorrhage | 4 | 2021 | 147 | 1.020 |
Why?
|
| Hematoma | 3 | 2020 | 84 | 0.900 |
Why?
|
| Space Flight | 3 | 2020 | 98 | 0.880 |
Why?
|
| Anticoagulants | 2 | 2021 | 559 | 0.860 |
Why?
|
| Brain Edema | 2 | 2021 | 62 | 0.820 |
Why?
|
| Subarachnoid Hemorrhage | 2 | 2020 | 62 | 0.750 |
Why?
|
| Atrial Fibrillation | 2 | 2021 | 694 | 0.710 |
Why?
|
| Diuretics, Osmotic | 1 | 2021 | 4 | 0.710 |
Why?
|
| Mannitol | 1 | 2021 | 40 | 0.700 |
Why?
|
| Saline Solution, Hypertonic | 1 | 2021 | 21 | 0.700 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2021 | 260 | 0.690 |
Why?
|
| Glasgow Coma Scale | 2 | 2020 | 194 | 0.630 |
Why?
|
| Neurology | 1 | 2021 | 101 | 0.620 |
Why?
|
| Common Data Elements | 1 | 2019 | 6 | 0.620 |
Why?
|
| Aneurysm, Ruptured | 1 | 2019 | 30 | 0.610 |
Why?
|
| Percutaneous Coronary Intervention | 1 | 2021 | 263 | 0.520 |
Why?
|
| Fibrinolytic Agents | 1 | 2018 | 195 | 0.510 |
Why?
|
| Thrombolytic Therapy | 1 | 2018 | 203 | 0.510 |
Why?
|
| Time-to-Treatment | 1 | 2018 | 195 | 0.510 |
Why?
|
| Secondary Prevention | 1 | 2016 | 214 | 0.460 |
Why?
|
| Coronary Artery Disease | 1 | 2021 | 807 | 0.430 |
Why?
|
| Thrombectomy | 2 | 2021 | 105 | 0.320 |
Why?
|
| Safe Sex | 1 | 2009 | 16 | 0.320 |
Why?
|
| Adaptation, Physiological | 3 | 2020 | 257 | 0.310 |
Why?
|
| Condoms | 1 | 2009 | 50 | 0.310 |
Why?
|
| Sexual Partners | 1 | 2009 | 79 | 0.310 |
Why?
|
| Object Attachment | 1 | 2009 | 55 | 0.300 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2009 | 91 | 0.290 |
Why?
|
| History, 20th Century | 2 | 2021 | 368 | 0.280 |
Why?
|
| Intracranial Pressure | 2 | 2019 | 179 | 0.260 |
Why?
|
| Blood Pressure | 3 | 2020 | 1302 | 0.250 |
Why?
|
| Hospitals, Rural | 1 | 2025 | 16 | 0.240 |
Why?
|
| Guillain-Barre Syndrome | 1 | 2025 | 29 | 0.240 |
Why?
|
| Hospitals, Urban | 1 | 2025 | 98 | 0.230 |
Why?
|
| Humans | 19 | 2025 | 126134 | 0.220 |
Why?
|
| Middle Aged | 9 | 2025 | 27402 | 0.200 |
Why?
|
| Checklist | 1 | 2022 | 96 | 0.180 |
Why?
|
| History, 18th Century | 1 | 2021 | 70 | 0.170 |
Why?
|
| Treatment Outcome | 3 | 2021 | 12393 | 0.170 |
Why?
|
| History, 19th Century | 1 | 2021 | 109 | 0.170 |
Why?
|
| Risk Factors | 5 | 2021 | 10374 | 0.160 |
Why?
|
| Vasospasm, Intracranial | 1 | 2020 | 18 | 0.160 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2021 | 200 | 0.160 |
Why?
|
| Hospital Mortality | 2 | 2025 | 969 | 0.160 |
Why?
|
| Risk Assessment | 2 | 2021 | 3422 | 0.160 |
Why?
|
| Brain | 3 | 2020 | 3031 | 0.160 |
Why?
|
| Vasoconstriction | 1 | 2020 | 93 | 0.160 |
Why?
|
| Astronauts | 1 | 2019 | 38 | 0.160 |
Why?
|
| National Library of Medicine (U.S.) | 1 | 2019 | 3 | 0.160 |
Why?
|
| National Institute of Neurological Disorders and Stroke (U.S.) | 1 | 2019 | 11 | 0.160 |
Why?
|
| Hyponatremia | 1 | 2020 | 71 | 0.150 |
Why?
|
| Sodium | 1 | 2020 | 273 | 0.150 |
Why?
|
| Vision, Ocular | 1 | 2019 | 128 | 0.150 |
Why?
|
| Intracranial Aneurysm | 1 | 2019 | 77 | 0.150 |
Why?
|
| Magnesium | 1 | 2019 | 118 | 0.140 |
Why?
|
| Texas | 3 | 2020 | 3536 | 0.140 |
Why?
|
| Aged | 7 | 2025 | 20078 | 0.140 |
Why?
|
| Cost Savings | 1 | 2018 | 76 | 0.140 |
Why?
|
| Single-Blind Method | 1 | 2018 | 231 | 0.140 |
Why?
|
| Hospitalization | 2 | 2025 | 1811 | 0.140 |
Why?
|
| Retrospective Studies | 6 | 2025 | 16831 | 0.140 |
Why?
|
| Spectrum Analysis | 1 | 2018 | 62 | 0.140 |
Why?
|
| Neurophysiological Monitoring | 1 | 2018 | 35 | 0.140 |
Why?
|
| Drug Administration Schedule | 1 | 2018 | 735 | 0.130 |
Why?
|
| Quality Improvement | 1 | 2022 | 673 | 0.130 |
Why?
|
| Prognosis | 3 | 2020 | 4697 | 0.120 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2021 | 1179 | 0.120 |
Why?
|
| Warfarin | 1 | 2016 | 109 | 0.120 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 1 | 2015 | 109 | 0.120 |
Why?
|
| Stents | 1 | 2021 | 732 | 0.110 |
Why?
|
| Intracranial Hypertension | 1 | 2015 | 111 | 0.110 |
Why?
|
| Cost-Benefit Analysis | 1 | 2016 | 527 | 0.110 |
Why?
|
| Male | 9 | 2025 | 62225 | 0.100 |
Why?
|
| Patient Education as Topic | 1 | 2016 | 449 | 0.100 |
Why?
|
| Biomedical Research | 1 | 2019 | 530 | 0.100 |
Why?
|
| Female | 9 | 2025 | 68037 | 0.100 |
Why?
|
| Endarterectomy, Carotid | 1 | 2012 | 76 | 0.090 |
Why?
|
| Nervous System Diseases | 1 | 2015 | 391 | 0.090 |
Why?
|
| Carotid Stenosis | 1 | 2012 | 101 | 0.090 |
Why?
|
| Renal Dialysis | 1 | 2018 | 902 | 0.080 |
Why?
|
| Prospective Studies | 2 | 2018 | 6178 | 0.080 |
Why?
|
| Kidney Failure, Chronic | 1 | 2018 | 902 | 0.080 |
Why?
|
| United States | 2 | 2025 | 11187 | 0.070 |
Why?
|
| Cross-Sectional Studies | 2 | 2015 | 3658 | 0.060 |
Why?
|
| Adult | 5 | 2025 | 30314 | 0.060 |
Why?
|
| Postoperative Complications | 1 | 2012 | 2981 | 0.040 |
Why?
|
| Animals | 1 | 2021 | 33230 | 0.040 |
Why?
|
| Biomarkers | 2 | 2020 | 3149 | 0.040 |
Why?
|
| Length of Stay | 1 | 2025 | 1318 | 0.040 |
Why?
|
| Choroid Diseases | 1 | 2019 | 17 | 0.040 |
Why?
|
| Papilledema | 1 | 2019 | 35 | 0.040 |
Why?
|
| Surveys and Questionnaires | 1 | 2009 | 3895 | 0.040 |
Why?
|
| Area Under Curve | 1 | 2020 | 293 | 0.040 |
Why?
|
| Vision Disorders | 1 | 2019 | 155 | 0.040 |
Why?
|
| Proof of Concept Study | 1 | 2018 | 33 | 0.030 |
Why?
|
| Osmolar Concentration | 1 | 2018 | 151 | 0.030 |
Why?
|
| Clinical Decision-Making | 1 | 2020 | 297 | 0.030 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2020 | 380 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2020 | 591 | 0.030 |
Why?
|
| Adolescent | 2 | 2015 | 19986 | 0.030 |
Why?
|
| Spinal Puncture | 1 | 2015 | 45 | 0.030 |
Why?
|
| Intraocular Pressure | 1 | 2015 | 125 | 0.030 |
Why?
|
| ROC Curve | 1 | 2015 | 566 | 0.030 |
Why?
|
| Age Factors | 1 | 2020 | 2766 | 0.030 |
Why?
|
| Incidence | 1 | 2020 | 3193 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2020 | 2012 | 0.020 |
Why?
|
| Time Factors | 1 | 2020 | 6030 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 6582 | 0.020 |
Why?
|
| Young Adult | 1 | 2015 | 9635 | 0.010 |
Why?
|